Basket | Login


Brian Lawlor


Professor Lawlor’s research interests are in the early detection, diagnosis and treatment of Alzheimer's disease, the neurobiology and treatment of behavioural and psychological symptoms in dementia and mental disorders in the community dwelling elderly.   Prof. Lawlor is active in clinical trials and cohort studies of Alzheimer's disease and cross sectional and longitudinal studies of the mental health of community dwelling older people. The overarching aims of Prof. Lawlor’s research programmes are to develop clinical, neuropsychological and biological markers of Alzheimer's disease at the earliest possible stage, to test promising new treatments in clinical populations and to develop scalable interventions for brain health and dementia prevention.

Professor Lawlor’s research is carried out in partnership with disciplines from basic science and psychology, ranging from development of animal models of Alzheimer's disease to health service development, clinical trials and prevention. Prof. Lawlor is currently participating in a number of collaborative studies in biomarker development and disease modification in Alzheimer’s disease. He is lead PI and co-ordinator of NILVAD , an FP 7 funded investigator driven clinical trial examining the effectiveness of nilvadipine a calcium channel blocker as a disease modifying treatment in Alzheimer’s disease, is the Irish co-ordinator for BiomarkAPD and has established the Irish Network for Biomarkers in Neurodegeneration (IN-BIND)

Before returning to Dublin in 1991 to take up his current position Prof. Lawlor was Chief of Geriatric Psychiatry at Mount Sinai Hospital, New York. 



Last Updated: Wednesday 15 April 2015